Home > Healthcare > Pharmaceuticals > Active Pharmaceutical Ingredients > Methotrexate Market

Methotrexate Market Trends

  • Report ID: GMI6835
  • Published Date: Oct 2023
  • Report Format: PDF

Methotrexate Market Trends

Rising technological advancements and the demand for personalized medicine have led to innovations in drug development and treatment strategies. Methotrexate is a medication commonly used in the treatment of various medical conditions, including cancer, autoimmune diseases, and rheumatoid arthritis. With the use of advancements in injectable technologies, methotrexate injections can be made more practical, secure, and patient-compliant. Better equipment, including auto-injectors and wearable injectors will be able to improve the patient experience and create potential for differentiation.
 

For instance, Atomwise utilizes artificial intelligence (AI) in drug discovery. MethoAI is an example of the way AI is used to design novel methotrexate derivatives with improved efficacy and reduced side effects, tailoring treatments to individual patient needs. Additionally, HealthTech Inc. offers a mobile app called MedMethoCare that helps patients track their methotrexate treatment, record symptoms, and receive personalized reminders and dosing instructions based on their health data and treatment response. Therefore, increasing technological advancements and product approvals are projected to accelerate industry expansion.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global methotrexate industry was valued at USD 553 million in 2022 and is estimated to account for USD 921 million by 2032 as methotrexate is a versatile medication that is used to treat a variety of medical conditions, including cancer, autoimmune diseases, and severe skin disorders.

Rheumatoid arthritis (RA) segment accounted for over USD 250 million in the year 2022, supported by the growing prevalence of people suffering from the disease in developed as well as developing economies.

U.S. methotrexate market accounted for USD 165.3 million in 2022 and is predicted to witness substantial growth through 2032, attributed to the significant healthcare expenditure, supportive government initiatives, high number of pharmaceutical companies, and rising disease awareness.

Novartis AG (Sandoz), Merck & Co., Inc, Lonza, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd, Fermion (Orion Corporation), Avra Laboratories Pvt Ltd, LGM Pharma, and Rochem International Inc among others.

Methotrexate Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 230
  • Countries covered: 23
  • Pages: 164
 Download Free Sample